Marchés français ouverture 4 h 43 min
  • Dow Jones

    28 335,57
    -28,13 (-0,10 %)
     
  • Nasdaq

    11 548,28
    +42,28 (+0,37 %)
     
  • Nikkei 225

    23 514,41
    -2,18 (-0,01 %)
     
  • EUR/USD

    1,1843
    -0,0025 (-0,21 %)
     
  • HANG SENG

    24 918,78
    +132,68 (+0,54 %)
     
  • BTC-EUR

    11 088,43
    +98,34 (+0,89 %)
     
  • CMC Crypto 200

    264,10
    +2,64 (+1,01 %)
     
  • S&P 500

    3 465,39
    +11,90 (+0,34 %)
     

Global Influenza Diagnostics Industry

ReportLinker
·23 min de lecture

Global Influenza Diagnostics Market to Reach $3. 6 Billion by 2027. Amid the COVID-19 crisis, the global market for Influenza Diagnostics estimated at US$2. 5 Billion in the year 2020, is projected to reach a revised size of US$3.

New York, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Influenza Diagnostics Industry" - https://www.reportlinker.com/p05957114/?utm_source=GNW
6 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027. RIDT, one of the segments analyzed in the report, is projected to record a 5.8% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RT-PCR segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $685 Million, While China is Forecast to Grow at 8% CAGR

The Influenza Diagnostics market in the U.S. is estimated at US$685 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$755.1 Million by the year 2027 trailing a CAGR of 8.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Cell Culture Segment to Record 4.6% CAGR

In the global Cell Culture segment, USA, Canada, Japan, China and Europe will drive the 4.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$245.6 Million in the year 2020 will reach a projected size of US$326.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$484 Million by the year 2027, while Latin America will expand at a 5.6% CAGR through the analysis period. We bring years of research experience to this 6th edition of our report. The 278-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Alere, Inc.

  • Analytik Jena AG

  • Becton, Dickinson and Company

  • DiaSorin SpA

  • F. Hoffmann-La Roche AG

  • Luminex Corporation

  • Meridian Bioscience, Inc.

  • Quidel Corporation

  • SA Scientific, Ltd.

  • Thermo Fisher Scientific, Inc.




Read the full report: https://www.reportlinker.com/p05957114/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Influenza Diagnostics Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Influenza Diagnostics Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Influenza Diagnostics Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Influenza Diagnostics Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: RIDT (Test Type) World Market by Region/Country in US$
Million: 2020 to 2027

Table 5: RIDT (Test Type) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 6: RIDT (Test Type) Market Share Breakdown of Worldwide
Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: RT-PCR (Test Type) Potential Growth Markets Worldwide
in US$ Million: 2020 to 2027

Table 8: RT-PCR (Test Type) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019

Table 9: RT-PCR (Test Type) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: Cell Culture (Test Type) Geographic Market Spread
Worldwide in US$ Million: 2020 to 2027

Table 11: Cell Culture (Test Type) Region Wise Breakdown of
Global Historic Demand in US$ Million: 2012 to 2019

Table 12: Cell Culture (Test Type) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 13: Other Test Types (Test Type) World Market Estimates
and Forecasts by Region/Country in US$ Million: 2020 to 2027

Table 14: Other Test Types (Test Type) Market Historic Review
by Region/Country in US$ Million: 2012 to 2019

Table 15: Other Test Types (Test Type) Market Share Breakdown
by Region/Country: 2012 VS 2020 VS 2027

Table 16: Hospitals (End-Use) Worldwide Latent Demand Forecasts
in US$ Million by Region/Country: 2020-2027

Table 17: Hospitals (End-Use) Global Historic Analysis in US$
Million by Region/Country: 2012-2019

Table 18: Hospitals (End-Use) Distribution of Global Sales by
Region/Country: 2012 VS 2020 VS 2027

Table 19: POCT (End-Use) Sales Estimates and Forecasts in US$
Million by Region/Country for the Years 2020 through 2027

Table 20: POCT (End-Use) Analysis of Historic Sales in US$
Million by Region/Country for the Years 2012 to 2019

Table 21: POCT (End-Use) Global Market Share Distribution by
Region/Country for 2012, 2020, and 2027

Table 22: Laboratories (End-Use) Global Opportunity Assessment
in US$ Million by Region/Country: 2020-2027

Table 23: Laboratories (End-Use) Historic Sales Analysis in US$
Million by Region/Country: 2012-2019

Table 24: Laboratories (End-Use) Percentage Share Breakdown of
Global Sales by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Influenza Diagnostics Market Share (in %) by Company: 2019 &
2025
Market Analytics
Table 25: United States Influenza Diagnostics Market Estimates
and Projections in US$ Million by Test Type: 2020 to 2027

Table 26: Influenza Diagnostics Market in the United States by
Test Type: A Historic Review in US$ Million for 2012-2019

Table 27: United States Influenza Diagnostics Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 28: United States Influenza Diagnostics Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 29: Influenza Diagnostics Historic Demand Patterns in the
United States by End-Use in US$ Million for 2012-2019

Table 30: Influenza Diagnostics Market Share Breakdown in the
United States by End-Use: 2012 VS 2020 VS 2027

CANADA
Table 31: Canadian Influenza Diagnostics Market Estimates and
Forecasts in US$ Million by Test Type: 2020 to 2027

Table 32: Canadian Influenza Diagnostics Historic Market Review
by Test Type in US$ Million: 2012-2019

Table 33: Influenza Diagnostics Market in Canada: Percentage
Share Breakdown of Sales by Test Type for 2012, 2020, and 2027

Table 34: Canadian Influenza Diagnostics Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027

Table 35: Influenza Diagnostics Market in Canada: Summarization
of Historic Demand Patterns in US$ Million by End-Use for
2012-2019

Table 36: Canadian Influenza Diagnostics Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

JAPAN
Table 37: Japanese Market for Influenza Diagnostics: Annual
Sales Estimates and Projections in US$ Million by Test Type for
the Period 2020-2027

Table 38: Influenza Diagnostics Market in Japan: Historic Sales
Analysis in US$ Million by Test Type for the Period 2012-2019

Table 39: Japanese Influenza Diagnostics Market Share Analysis
by Test Type: 2012 VS 2020 VS 2027

Table 40: Japanese Demand Estimates and Forecasts for Influenza
Diagnostics in US$ Million by End-Use: 2020 to 2027

Table 41: Japanese Influenza Diagnostics Market in US$ Million
by End-Use: 2012-2019

Table 42: Influenza Diagnostics Market Share Shift in Japan by
End-Use: 2012 VS 2020 VS 2027

CHINA
Table 43: Chinese Influenza Diagnostics Market Growth Prospects
in US$ Million by Test Type for the Period 2020-2027

Table 44: Influenza Diagnostics Historic Market Analysis in
China in US$ Million by Test Type: 2012-2019

Table 45: Chinese Influenza Diagnostics Market by Test Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 46: Chinese Demand for Influenza Diagnostics in US$
Million by End-Use: 2020 to 2027

Table 47: Influenza Diagnostics Market Review in China in US$
Million by End-Use: 2012-2019

Table 48: Chinese Influenza Diagnostics Market Share Breakdown
by End-Use: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Influenza Diagnostics Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 49: European Influenza Diagnostics Market Demand Scenario
in US$ Million by Region/Country: 2020-2027

Table 50: Influenza Diagnostics Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019

Table 51: European Influenza Diagnostics Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027

Table 52: European Influenza Diagnostics Market Estimates and
Forecasts in US$ Million by Test Type: 2020-2027

Table 53: Influenza Diagnostics Market in Europe in US$ Million
by Test Type: A Historic Review for the Period 2012-2019

Table 54: European Influenza Diagnostics Market Share Breakdown
by Test Type: 2012 VS 2020 VS 2027

Table 55: European Influenza Diagnostics Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027

Table 56: Influenza Diagnostics Market in Europe: Summarization
of Historic Demand in US$ Million by End-Use for the Period
2012-2019

Table 57: European Influenza Diagnostics Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

FRANCE
Table 58: Influenza Diagnostics Market in France by Test Type:
Estimates and Projections in US$ Million for the Period
2020-2027

Table 59: French Influenza Diagnostics Historic Market Scenario
in US$ Million by Test Type: 2012-2019

Table 60: French Influenza Diagnostics Market Share Analysis by
Test Type: 2012 VS 2020 VS 2027

Table 61: Influenza Diagnostics Quantitative Demand Analysis in
France in US$ Million by End-Use: 2020-2027

Table 62: French Influenza Diagnostics Historic Market Review
in US$ Million by End-Use: 2012-2019

Table 63: French Influenza Diagnostics Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027

GERMANY
Table 64: Influenza Diagnostics Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Test Type for the
Period 2020-2027

Table 65: German Influenza Diagnostics Historic Market Analysis
in US$ Million by Test Type: 2012-2019

Table 66: German Influenza Diagnostics Market Share Breakdown
by Test Type: 2012 VS 2020 VS 2027

Table 67: Influenza Diagnostics Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 68: German Influenza Diagnostics Market in Retrospect in
US$ Million by End-Use: 2012-2019

Table 69: Influenza Diagnostics Market Share Distribution in
Germany by End-Use: 2012 VS 2020 VS 2027

ITALY
Table 70: Italian Influenza Diagnostics Market Growth Prospects
in US$ Million by Test Type for the Period 2020-2027

Table 71: Influenza Diagnostics Historic Market Analysis in
Italy in US$ Million by Test Type: 2012-2019

Table 72: Italian Influenza Diagnostics Market by Test Type:
Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 73: Italian Demand for Influenza Diagnostics in US$
Million by End-Use: 2020 to 2027

Table 74: Influenza Diagnostics Market Review in Italy in US$
Million by End-Use: 2012-2019

Table 75: Italian Influenza Diagnostics Market Share Breakdown
by End-Use: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 76: United Kingdom Market for Influenza Diagnostics:
Annual Sales Estimates and Projections in US$ Million by Test
Type for the Period 2020-2027

Table 77: Influenza Diagnostics Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Test Type for the
Period 2012-2019

Table 78: United Kingdom Influenza Diagnostics Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027

Table 79: United Kingdom Demand Estimates and Forecasts for
Influenza Diagnostics in US$ Million by End-Use: 2020 to 2027

Table 80: United Kingdom Influenza Diagnostics Market in US$
Million by End-Use: 2012-2019

Table 81: Influenza Diagnostics Market Share Shift in the
United Kingdom by End-Use: 2012 VS 2020 VS 2027

SPAIN
Table 82: Spanish Influenza Diagnostics Market Estimates and
Forecasts in US$ Million by Test Type: 2020 to 2027

Table 83: Spanish Influenza Diagnostics Historic Market Review
by Test Type in US$ Million: 2012-2019

Table 84: Influenza Diagnostics Market in Spain: Percentage
Share Breakdown of Sales by Test Type for 2012, 2020, and 2027

Table 85: Spanish Influenza Diagnostics Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027

Table 86: Influenza Diagnostics Market in Spain: Summarization
of Historic Demand Patterns in US$ Million by End-Use for
2012-2019

Table 87: Spanish Influenza Diagnostics Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

RUSSIA
Table 88: Russian Influenza Diagnostics Market Estimates and
Projections in US$ Million by Test Type: 2020 to 2027

Table 89: Influenza Diagnostics Market in Russia by Test Type:
A Historic Review in US$ Million for 2012-2019

Table 90: Russian Influenza Diagnostics Market Share Breakdown
by Test Type: 2012 VS 2020 VS 2027

Table 91: Russian Influenza Diagnostics Latent Demand Forecasts
in US$ Million by End-Use: 2020 to 2027

Table 92: Influenza Diagnostics Historic Demand Patterns in
Russia by End-Use in US$ Million for 2012-2019

Table 93: Influenza Diagnostics Market Share Breakdown in
Russia by End-Use: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 94: Rest of Europe Influenza Diagnostics Market Estimates
and Forecasts in US$ Million by Test Type: 2020-2027

Table 95: Influenza Diagnostics Market in Rest of Europe in US$
Million by Test Type: A Historic Review for the Period
2012-2019

Table 96: Rest of Europe Influenza Diagnostics Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 97: Rest of Europe Influenza Diagnostics Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027

Table 98: Influenza Diagnostics Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 99: Rest of Europe Influenza Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 100: Asia-Pacific Influenza Diagnostics Market Estimates
and Forecasts in US$ Million by Region/Country: 2020-2027

Table 101: Influenza Diagnostics Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2012-2019

Table 102: Asia-Pacific Influenza Diagnostics Market Share
Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 103: Influenza Diagnostics Market in Asia-Pacific by Test
Type: Estimates and Projections in US$ Million for the Period
2020-2027

Table 104: Asia-Pacific Influenza Diagnostics Historic Market
Scenario in US$ Million by Test Type: 2012-2019

Table 105: Asia-Pacific Influenza Diagnostics Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027

Table 106: Influenza Diagnostics Quantitative Demand Analysis
in Asia-Pacific in US$ Million by End-Use: 2020-2027

Table 107: Asia-Pacific Influenza Diagnostics Historic Market
Review in US$ Million by End-Use: 2012-2019

Table 108: Asia-Pacific Influenza Diagnostics Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

AUSTRALIA
Table 109: Influenza Diagnostics Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Test Type
for the Period 2020-2027

Table 110: Australian Influenza Diagnostics Historic Market
Analysis in US$ Million by Test Type: 2012-2019

Table 111: Australian Influenza Diagnostics Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 112: Influenza Diagnostics Market in Australia: Annual
Sales Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 113: Australian Influenza Diagnostics Market in
Retrospect in US$ Million by End-Use: 2012-2019

Table 114: Influenza Diagnostics Market Share Distribution in
Australia by End-Use: 2012 VS 2020 VS 2027

INDIA
Table 115: Indian Influenza Diagnostics Market Estimates and
Forecasts in US$ Million by Test Type: 2020 to 2027

Table 116: Indian Influenza Diagnostics Historic Market Review
by Test Type in US$ Million: 2012-2019

Table 117: Influenza Diagnostics Market in India: Percentage
Share Breakdown of Sales by Test Type for 2012, 2020, and 2027

Table 118: Indian Influenza Diagnostics Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027

Table 119: Influenza Diagnostics Market in India: Summarization
of Historic Demand Patterns in US$ Million by End-Use for
2012-2019

Table 120: Indian Influenza Diagnostics Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

SOUTH KOREA
Table 121: Influenza Diagnostics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by Test Type
for the Period 2020-2027

Table 122: South Korean Influenza Diagnostics Historic Market
Analysis in US$ Million by Test Type: 2012-2019

Table 123: Influenza Diagnostics Market Share Distribution in
South Korea by Test Type: 2012 VS 2020 VS 2027

Table 124: Influenza Diagnostics Market in South Korea: Recent
Past, Current and Future Analysis in US$ Million by End-Use for
the Period 2020-2027

Table 125: South Korean Influenza Diagnostics Historic Market
Analysis in US$ Million by End-Use: 2012-2019

Table 126: Influenza Diagnostics Market Share Distribution in
South Korea by End-Use: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 127: Rest of Asia-Pacific Market for Influenza
Diagnostics: Annual Sales Estimates and Projections in US$
Million by Test Type for the Period 2020-2027

Table 128: Influenza Diagnostics Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Test
Type for the Period 2012-2019

Table 129: Rest of Asia-Pacific Influenza Diagnostics Market
Share Analysis by Test Type: 2012 VS 2020 VS 2027

Table 130: Rest of Asia-Pacific Demand Estimates and Forecasts
for Influenza Diagnostics in US$ Million by End-Use: 2020 to
2027

Table 131: Rest of Asia-Pacific Influenza Diagnostics Market in
US$ Million by End-Use: 2012-2019

Table 132: Influenza Diagnostics Market Share Shift in Rest of
Asia-Pacific by End-Use: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 133: Latin American Influenza Diagnostics Market Trends
by Region/Country in US$ Million: 2020-2027

Table 134: Influenza Diagnostics Market in Latin America in US$
Million by Region/Country: A Historic Perspective for the
Period 2012-2019

Table 135: Latin American Influenza Diagnostics Market
Percentage Breakdown of Sales by Region/Country: 2012, 2020,
and 2027

Table 136: Latin American Influenza Diagnostics Market Growth
Prospects in US$ Million by Test Type for the Period 2020-2027

Table 137: Influenza Diagnostics Historic Market Analysis in
Latin America in US$ Million by Test Type: 2012-2019

Table 138: Latin American Influenza Diagnostics Market by Test
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 139: Latin American Demand for Influenza Diagnostics in
US$ Million by End-Use: 2020 to 2027

Table 140: Influenza Diagnostics Market Review in Latin America
in US$ Million by End-Use: 2012-2019

Table 141: Latin American Influenza Diagnostics Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027

ARGENTINA
Table 142: Argentinean Influenza Diagnostics Market Estimates
and Forecasts in US$ Million by Test Type: 2020-2027

Table 143: Influenza Diagnostics Market in Argentina in US$
Million by Test Type: A Historic Review for the Period
2012-2019

Table 144: Argentinean Influenza Diagnostics Market Share
Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 145: Argentinean Influenza Diagnostics Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027

Table 146: Influenza Diagnostics Market in Argentina:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 147: Argentinean Influenza Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

BRAZIL
Table 148: Influenza Diagnostics Market in Brazil by Test Type:
Estimates and Projections in US$ Million for the Period
2020-2027

Table 149: Brazilian Influenza Diagnostics Historic Market
Scenario in US$ Million by Test Type: 2012-2019

Table 150: Brazilian Influenza Diagnostics Market Share
Analysis by Test Type: 2012 VS 2020 VS 2027

Table 151: Influenza Diagnostics Quantitative Demand Analysis
in Brazil in US$ Million by End-Use: 2020-2027

Table 152: Brazilian Influenza Diagnostics Historic Market
Review in US$ Million by End-Use: 2012-2019

Table 153: Brazilian Influenza Diagnostics Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027

MEXICO
Table 154: Influenza Diagnostics Market in Mexico: Recent Past,
Current and Future Analysis in US$ Million by Test Type for the
Period 2020-2027

Table 155: Mexican Influenza Diagnostics Historic Market
Analysis in US$ Million by Test Type: 2012-2019

Table 156: Mexican Influenza Diagnostics Market Share Breakdown
by Test Type: 2012 VS 2020 VS 2027

Table 157: Influenza Diagnostics Market in Mexico: Annual Sales
Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027

Table 158: Mexican Influenza Diagnostics Market in Retrospect
in US$ Million by End-Use: 2012-2019

Table 159: Influenza Diagnostics Market Share Distribution in
Mexico by End-Use: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 160: Rest of Latin America Influenza Diagnostics Market
Estimates and Projections in US$ Million by Test Type: 2020 to
2027

Table 161: Influenza Diagnostics Market in Rest of Latin
America by Test Type: A Historic Review in US$ Million for
2012-2019

Table 162: Rest of Latin America Influenza Diagnostics Market
Share Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 163: Rest of Latin America Influenza Diagnostics Latent
Demand Forecasts in US$ Million by End-Use: 2020 to 2027

Table 164: Influenza Diagnostics Historic Demand Patterns in
Rest of Latin America by End-Use in US$ Million for 2012-2019

Table 165: Influenza Diagnostics Market Share Breakdown in Rest
of Latin America by End-Use: 2012 VS 2020 VS 2027

MIDDLE EAST
Table 166: The Middle East Influenza Diagnostics Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 167: Influenza Diagnostics Market in the Middle East by
Region/Country in US$ Million: 2012-2019

Table 168: The Middle East Influenza Diagnostics Market Share
Breakdown by Region/Country: 2012, 2020, and 2027

Table 169: The Middle East Influenza Diagnostics Market
Estimates and Forecasts in US$ Million by Test Type: 2020 to
2027

Table 170: The Middle East Influenza Diagnostics Historic
Market by Test Type in US$ Million: 2012-2019

Table 171: Influenza Diagnostics Market in the Middle East:
Percentage Share Breakdown of Sales by Test Type for 2012,2020,
and 2027

Table 172: The Middle East Influenza Diagnostics Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027

Table 173: Influenza Diagnostics Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019

Table 174: The Middle East Influenza Diagnostics Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027

IRAN
Table 175: Iranian Market for Influenza Diagnostics: Annual
Sales Estimates and Projections in US$ Million by Test Type for
the Period 2020-2027

Table 176: Influenza Diagnostics Market in Iran: Historic Sales
Analysis in US$ Million by Test Type for the Period 2012-2019

Table 177: Iranian Influenza Diagnostics Market Share Analysis
by Test Type: 2012 VS 2020 VS 2027

Table 178: Iranian Demand Estimates and Forecasts for Influenza
Diagnostics in US$ Million by End-Use: 2020 to 2027

Table 179: Iranian Influenza Diagnostics Market in US$ Million
by End-Use: 2012-2019

Table 180: Influenza Diagnostics Market Share Shift in Iran by
End-Use: 2012 VS 2020 VS 2027

ISRAEL
Table 181: Israeli Influenza Diagnostics Market Estimates and
Forecasts in US$ Million by Test Type: 2020-2027

Table 182: Influenza Diagnostics Market in Israel in US$
Million by Test Type: A Historic Review for the Period
2012-2019

Table 183: Israeli Influenza Diagnostics Market Share Breakdown
by Test Type: 2012 VS 2020 VS 2027

Table 184: Israeli Influenza Diagnostics Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027

Table 185: Influenza Diagnostics Market in Israel:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019

Table 186: Israeli Influenza Diagnostics Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027

SAUDI ARABIA
Table 187: Saudi Arabian Influenza Diagnostics Market Growth
Prospects in US$ Million by Test Type for the Period 2020-2027

Table 188: Influenza Diagnostics Historic Market Analysis in
Saudi Arabia in US$ Million by Test Type: 2012-2019

Table 189: Saudi Arabian Influenza Diagnostics Market by Test
Type: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 190: Saudi Arabian Demand for Influenza Diagnostics in
US$ Million by End-Use: 2020 to 2027

Table 191: Influenza Diagnostics Market Review in Saudi Arabia
in US$ Million by End-Use: 2012-2019

Table 192: Saudi Arabian Influenza Diagnostics Market Share
Breakdown by End-Use: 2012 VS 2020 VS 2027

UNITED ARAB EMIRATES
Table 193: Influenza Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Test Type for the Period 2020-2027

Table 194: United Arab Emirates Influenza Diagnostics Historic
Market Analysis in US$ Million by Test Type: 2012-2019

Table 195: Influenza Diagnostics Market Share Distribution in
United Arab Emirates by Test Type: 2012 VS 2020 VS 2027

Table 196: Influenza Diagnostics Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by End-Use for the Period 2020-2027

Table 197: United Arab Emirates Influenza Diagnostics Historic
Market Analysis in US$ Million by End-Use: 2012-2019

Table 198: Influenza Diagnostics Market Share Distribution in
United Arab Emirates by End-Use: 2012 VS 2020 VS 2027

REST OF MIDDLE EAST
Table 199: Influenza Diagnostics Market in Rest of Middle East:
Recent Past, Current and Future Analysis in US$ Million by Test
Type for the Period 2020-2027

Table 200: Rest of Middle East Influenza Diagnostics Historic
Market Analysis in US$ Million by Test Type: 2012-2019

Table 201: Rest of Middle East Influenza Diagnostics Market
Share Breakdown by Test Type: 2012 VS 2020 VS 2027

Table 202: Influenza Diagnostics Market in Rest of Middle East:
Annual Sales Estimates and Forecasts in US$ Million by End-Use
for the Period 2020-2027

Table 203: Rest of Middle East Influenza Diagnostics Market in
Retrospect in US$ Million by End-Use: 2012-2019

Table 204: Influenza Diagnostics Market Share Distribution in
Rest of Middle East by End-Use: 2012 VS 2020 VS 2027

AFRICA
Table 205: African Influenza Diagnostics Market Estimates and
Projections in US$ Million by Test Type: 2020 to 2027

Table 206: Influenza Diagnostics Market in Africa by Test Type:
A Historic Review in US$ Million for 2012-2019

Table 207: African Influenza Diagnostics Market Share Breakdown
by Test Type: 2012 VS 2020 VS 2027

Table 208: African Influenza Diagnostics Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027

Table 209: Influenza Diagnostics Historic Demand Patterns in
Africa by End-Use in US$ Million for 2012-2019

Table 210: Influenza Diagnostics Market Share Breakdown in
Africa by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 38
Read the full report: https://www.reportlinker.com/p05957114/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001